feedback

Course Director

Barbara P. Yawn, MD, MS, MSc
Barbara P. Yawn, MD, MS, MSc

University of Minnesota School of Medicine
Minneapolis, Minnesota

Faculty

MeiLan K. Han
MeiLan K. Han, MD, MS

University of Michigan Health System
Ann Arbor, Michigan

Thierry Troosters
Thierry Troosters, PT, PhD, FERS

Katholieke Universiteit Leuven
Leuven, Belgium

Jean M. Rommes, PhD

COPD Patient Advocate

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME
Credit Amount:0.75 Credits
Release Date:2017-Oct-27
Expiration Date:2018-Oct-25
Estimated Time for Completion:45 minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, a patient living with COPD joins a multidisciplinary panel of experts, including a family physician, a pulmonologist, and a physiotherapist, to discuss how to incorporate elements of pulmonary rehabilitation into COPD management plans, to review pharmacologic treatment options for patients with COPD, and to explain the importance of arming patients with self-management skills.

Upon completion of this activity, participants should be better able to:

  • Discuss the benefits of physical activity in patients with chronic obstructive pulmonary disease (COPD)
  • Employ multidisciplinary multimodal approaches to treating patients with COPD that include pharmacotherapy and elements of pulmonary rehabilitation
  • Apply effective strategies to educate patients with COPD about self-management skills

Target Audience

This activity has been designed to meet the educational needs of primary care physicians, pulmonary rehabilitation specialists, physician assistants, nurse practitioners, and other clinicians involved in the management of patients with COPD.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/MOC credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: October 27, 2017 - October 26, 2018
Time to Complete: 45 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity during the past 12 months.

Course Director and Moderator

Barbara P. Yawn, MD, MS, MSc
Department of Family and Community Health
University of Minnesota School of Medicine
Minneapolis, Minnesota

Barbara P. Yawn, MD, MS, MSc, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; ndd Medizintechnik AG; Novartis Pharmaceuticals Corporation; and Thermo Fisher Scientific Inc.
Other Financial or Material Support from Teva Pharmaceuticals. Dr. Barbara P. Yawn serves as an independent contractor for a free drug for PCORI trial.

Barbara P. Yawn, MD, MS, MSc, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: for COPD.

Faculty

MeiLan K. Han, MD, MS
Associate Professor of Internal Medicine
University of Michigan Health System
Department of Internal Medicine
Division of Pulmonary & Critical Care Medicine
Ann Arbor, Michigan

MeiLan K. Han, MD, MS, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; and Sunovion Pharmaceuticals Inc.
Grant/Research Support from Novartis Pharmaceuticals Corporation.

MeiLan K. Han, MD, MS, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: for COPD.

Thierry Troosters, PT, PhD, FERS
Department Rehabilitation Sciences
Pulmonary Rehabilitation
Katholieke Universiteit Leuven
Leuven, Belgium

Thierry Troosters, PT, PhD, FERS, has no financial interests/relationships or affiliations in relation to this activity.

Thierry Troosters, PT, PhD, FERS, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: for COPD.

Jean M. Rommes, PhD
COPD Patient Advocate

Jean M. Rommes, PhD, has a financial interest/relationship or affiliation in the form of:
Other Financial or Material Support from Board Member for COPD Foundation.

Jean M. Rommes, PhD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: for COPD.

CME Reviewers

Kaushal Patel, MD
Internal Medicine
Camp Hill, Pennsylvania

Kaushal Patel, MD, has no financial interests/relationships or affiliations in relation to this activity.

Tracy L. Greene, MSN, RN, NP-C
Consultant
Tampa, Florida

Tracy L. Greene, MSN, RN, NP-C, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Kate Nelson, PhD
PVI, PeerView Institute for Medical Education

Kate Nelson, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

ACPE Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME’s Program Reporting and Activity System (PARS). Individual or aggregated participant data may be shared with the funder of the activity.

Providership

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an independent educational grant from AstraZeneca LP.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

Copyright © 2000-2017, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.